You searched for "Ida Institute"
Take part in the FAMOUS study
Could your clinic be one of 40 NHS sites across the UK to participate in the FAMOUS study? Organisers need your help to improve the assessment and management of adult hearing loss.
Valsalva manoeuvre treatment of otitis media with effusion in adults
Otitis media with effusion (OME) is common in children but has a low prevalence in adults. There is some evidence to advocate middle ear inflation as a successful treatment for children with OME. This form of treatment is also recommended...
How to tackle the problem of ciprofloxacin-resistant ear infections?
The growing issue of ciprofloxacin-resistant ear organisms is certainly a pertinent one. The situation here in the UK, where ototoxic topical drops are frequently given initially in the presence of pus and a perforation, differs markedly from elsewhere where fluoroquinolones...Introduction to speech testing
Let’s get back to basics: Dr Schoepflin introduces the concepts behind speech testing for hearing care professionals. While pure tone threshold testing is considered the ‘gold standard’ for assessing auditory sensitivity, the results of pure tone testing provide only limited...
Inequitable access to cochlear implantation across the UK
Referral rates and uptake of cochlear implantation in the global adult population are low. Five audiology centres across England and Wales retrospectively explored data over a six-month period in late 2019, post implementation of new National Institute for Health and...
Person-centred care, enhancing audiology student understanding across the globe
Over 200 students registered for a multinational virtual event facilitated by the Ida Institute. The aim was to determine levels of student understanding and approaches to person-centred care (PCC), alongside the opportunity to evaluate the benefits of this approach to...
Chemo-radiation in elderly patients with head and neck cancers
Chemo-radiotherapy is the standard of care for organ preservation in stage three and four oropharyngeal cancer, prospective data on patients over 65 has not been available as they are usually excluded from randomised trials. This paper reviews the experience of...
